First Test Kits Approved for the Detection and Identification of Microbial Nucleic Acids by FISH in Clinical Specimen
ID-FISH Technology is the leader in the development of diagnostic assays for detection of malaria parasites directly from blood smears using our patented fluorescent in situ hybridization (FISH) technology. Two kits have recently been cleared by the US Food and Drug Administration (FDA). ID-FISH Plasmodium Genus Test Kit and ID-FISH Plasmodium falcicarum and P. vivax Combo Test Kit. The Genus kit detects all plasmodium species known to cause human disease, P. falciparum, P. vivax, P. malariae, P. ovale and P. knowlesi. The Combo kit detects and differentiates P. falciparum and P. vivax. Since these simple and cost-effective tests are highly specific, better management of malaria patients is possible around the world. With your support, we can provide the right diagnoses to millions suffering from malaria.
ID-FISH Technology Inc., a small company based in Palo Alto, CA, USA, is a pioneer in the Biotechnology Industry dedicated to the development of high quality, simple, rapid and inexpensive diagnostic test kits for the detection of infectious diseases in clinical samples using Fluorescent In Situ Hybridization (FISH) technology. We are committed to providing reliable testing that is accessible worldwide. The research and development of our FISH assays is done under the guidance of Dr. Jyotsna Shah, Chief Scientific Officer, who has over 30 years’ experience in the development of diagnostics for infectious diseases.
ID-FISH Technology is the leader in the development of diagnostic assays for detecting malaria, tuberculosis and other infectious diseases directly in clinical samples (e.g. blood smears, sputum and tissue samples), using our patented FISH technique. FISH is an inexpensive and highly efficient technology that exhibits the sensitivity and specificity demanded in today’s world where existing and newly emerging infectious diseases and drug resistance are responsible for much ill health and mortality in humans and animals. By optimizing fluorescent probe technology, ID-FISH overcomes many inadequacies in existing diagnostics. Babesiosis and bartonellosis FISH tests are already in use (offered as clinical tests by IGeneX Inc, Palo Alto, CA). In addition, we are the first to develop highly sensitive and specific FISH tests to detect malaria (caused by different Plasmodium species) directly in blood smears. Currently, FISH test kits are available for the detection of all five species of malaria parasites that cause human disease. Testing includes the ability to differentiate Plasmodium vivax, P. falciparum and the zoonotic parasite P. knowlesi from other malaria parasites. These simple and cost-effective tests facilitate the better management of malaria patients around the world. Furthermore, our tests for tuberculosis, babesiosis and bartonellosis are valuable for detecting infections in livestock and pets which not only cause serious disease in the animals but can also be transmitted to humans.
Looking to the future ID-FISH Technology is focused on and committed to providing adequate and reliable infectious disease tests for worldwide use. Our plans include the development of diagnostic FISH tests for leishmaniasis, relapsing fever andtyphoid fever.